8 Recruiting Migraine Phase 3 Clinical Trials
Active phase 3 studies for migraine enrolling across the USA. Verify eligibility and contact site coordinators.
All Migraine studiesPhase 3 Studies for Migraine
🔵 Active, Not Recruiting Phase3
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
📍 Central Research Associates /ID# 260161 — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
📍 Xenoscience Inc — Phoenix, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine
📍 Paradigm Clinical Research Center Inc — San Diego, California
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
📍 Central Research Associates, LLC (CRA) dba Flourish Research — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
📍 Rehabilitation & Neurological Services /ID# 229969 — Huntsville, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase3
Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines
📍 Advocate Christ Medical Center Emergency Department — Oak Lawn, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase3
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
📍 The Belinga Clinic — Fort Smith, Arkansas
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
📍 Yale University School of Medicine — New Haven, Connecticut
View Study & Checklist ➔